The review of the foreign experience on the financing of innovative medical technologies
| Autor: | D. V. Fedyaev, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, M. L. Lazareva, I. A. Zheleznyakova |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Pharmacology
Finance business.industry 030503 health policy & services Health Policy media_common.quotation_subject Public Health Environmental and Occupational Health Medical practice RM1-950 Payment Public healthcare financing of innovations 03 medical and health sciences Economics as a science 0302 clinical medicine ComputerApplications_MISCELLANEOUS innovations in public healthcare diagnosis-related groups Therapeutics. Pharmacology 030212 general & internal medicine 0305 other medical science business HB71-74 media_common |
| Zdroj: | Фармакоэкономика, Vol 13, Iss 3, Pp 316-323 (2020) |
| ISSN: | 2070-4933 2070-4909 |
| DOI: | 10.17749/2070-4909/farmakoekonomika.2020.055 |
| Popis: | The article presents a review of the foreign approaches to the mechanisms of financing of medical help and innovative medical technologies with the description of the implemented financial mechanisms of stimulation of innovations in foreign systems of public healthcare. Since the system of payment for diagnosis-related groups (DRG) does not contribute to the implementation of innovations in the medical practice, the majority of countries apply additional mechanisms of financing of innovative technologies in public healthcare such as single and additional payments, and target financing that was initially not associated with a DRG model. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|